Understanding relator status requirements under the False Claims Act

If you are considering reporting systemic fraud in a healthcare organization, relator status requirements are not a technicality. They determine whether you can file, whether you can stay in the case, and whether you are paid if the government recovers funds.

Under the federal False Claims Act (FCA), a relator is a private party who files a qui tam lawsuit on behalf of the United States for fraud involving false claims for government money or property. You act as a private plaintiff, the government is the real party in interest, and the case is styled “United States ex rel. [Your Name] v. [Defendant].” (Cornell Law School, USA Whistleblowers)

If you meet the FCA’s relator status requirements and the case succeeds, you may receive 15 to 30 percent of the recovery, plus a share of treble damages and civil penalties. That financial incentive is deliberate. It is designed to encourage insiders like you to step forward when federal healthcare programs are being defrauded (Cornell Law School, Wikipedia, USA Whistleblowers).

Who can be a relator and who cannot

In healthcare, most successful FCA relators are insiders. You are often a clinical professional, billing specialist, compliance officer, or executive who sees billing patterns or systemic practices that do not square with program rules.

A relator may be:

A private individual such as an employee, physician, or contractor
A trade association or labor union that has relevant information
In some cases, a federal government employee, if specific statutory and regulatory conditions are met (Price Benowitz, Wikipedia)

However, you must navigate restrictions that can disqualify you or limit your right to a reward.

Key relator eligibility rules

At a high level, you must:

Be a private party bringing the case on behalf of the United States, not the government itself
Possess non‑frivolous information about fraud involving federal funds
File the action under seal in federal court, giving the Department of Justice (DOJ) the first opportunity to investigate and intervene (USA Whistleblowers)
Comply with statutory bars such as prior public disclosure and certain defendant relationships

If DOJ declines to intervene, you may still pursue the case independently. You retain relator status, but the case is harder and carries more litigation risk for you and your counsel (USA Whistleblowers).

Restricted categories of potential relators

Congress and regulators have drawn sharp lines around who may serve as a relator or receive awards:

Active duty military personnel cannot serve as plaintiff‑relators when the wrongdoing they report arises from their military service (Price Benowitz)
Federal employees may, in some situations, qualify as relators, but they face tight restrictions and must confirm eligibility with experienced counsel before filing
Employees of the Department of Justice, the Securities and Exchange Commission, and certain regulatory agencies are barred from whistleblower awards under related SEC and CFTC programs, and similar principles can limit their role as FCA relators (Price Benowitz)
Foreign government employees cannot collect under SEC or CFTC whistleblower programs, and parallel concerns about sovereign interests and conflicts can complicate their FCA participation

If you work in a government or quasi‑government healthcare setting, you should assume there are additional eligibility issues until counsel confirms otherwise.

Attorneys also face special barriers. If you are an attorney trying to report potential fraud by your own client or prospective client, attorney‑client privilege and professional conduct rules can severely limit your ability to act as a relator or obtain an award (Price Benowitz).

Information and knowledge you must have

Relator status requirements are not just about who you are. They are also about what you know and how you know it.

To qualify as a relator in a qui tam action, you must possess information that substantiates the claim of fraud against the government. You are expected to provide the knowledge or facts on which the action is based (Wikipedia). Regulators and courts care deeply about:

Specificity
Reliability
Connection to actual or potential false claims to federal payers

The quality of your information

As a healthcare insider, you are in a strong position when you can offer:

Concrete examples of false claims, such as claim numbers, dates of service, or internal codes
Internal communications that show knowledge and intent within the organization
Policies, templates, or workflow diagrams that prove the fraud is systemic, not accidental
Corroborating witnesses who can support your account

By design, ex rel. actions rely on your detailed insider knowledge. The complaint is filed in the name of the state or United States “ex rel.” you, indicating that the government is proceeding based on the information you provided (Wikipedia).

You do not need to be the only person who knows about the misconduct, but you must offer something of value beyond what is already public. If all your information comes from public reports, published cases, or widely accessible data, you may be barred by the prior public disclosure rule, or your share of any recovery may be reduced.

Voluntary reporting is mandatory

Under FCA and related whistleblower frameworks, your disclosure must be voluntary. If you are compelled by court order, subpoena, or other compulsory process to disclose the information, you generally cannot qualify as a relator eligible for an award (Price Benowitz).

For healthcare executives and compliance officers, this matters. If you are already under investigation, or you are responding to a civil investigative demand or subpoena, your later attempt to position yourself as a relator may fail. You must engage experienced FCA counsel early, before you respond to government requests, if you may also have relator rights.

Filing, seal requirements and the role of the DOJ

The mechanics of filing are part of relator status requirements. If you skip these steps or mishandle them, you risk dismissal.

When you initiate a False Claims Act qui tam suit, you must:

File a sealed complaint in federal district court
Serve a disclosure statement and supporting evidence on DOJ
Keep the case confidential for as long as the court maintains the seal (USA Whistleblowers)

During the seal period, DOJ investigates and decides whether to:

Intervene and take over primary responsibility for litigating the case
Decline intervention and allow you and your counsel to proceed on the government’s behalf
Seek dismissal if the case is deficient or conflicts with enforcement priorities

Your cooperation with DOJ during this stage is a practical relator requirement. The more organized, credible, and responsive you are, the more likely the government is to see your case as viable.

If DOJ intervenes and the case succeeds, you can typically receive 15 to 25 percent of the recovery. If DOJ declines and you continue independently, your potential share rises to 25 to 30 percent, but so does your risk and the complexity of the litigation (USA Whistleblowers).

For a step‑by‑step look at the litigation lifecycle, you can review the process of a qui tam or whistleblower lawsuit.

Distinguishing relators from other whistleblowers

In healthcare organizations, “whistleblower” is often used broadly. You may report internally to compliance, externally to a state board, or to an accrediting body. Not all whistleblowers are relators.

A relator is a specific legal role. You are a private party who sues on behalf of the government in an FCA qui tam action with potential entitlement to a defined share of the recovery (USA Whistleblowers). Your claims must involve government funds, such as Medicare, Medicaid, TRICARE, VA, or federal grant money.

By contrast, a broader whistleblower might:

Report Stark or Anti‑Kickback concerns that have not yet generated false claims
Raise patient safety concerns that primarily implicate state tort law or accreditation
File complaints with licensing boards, professional societies, or corporate hotlines

Those actions can still be protected under various federal and state whistleblower laws, and you may have strong anti‑retaliation rights. They simply do not make you a relator or guarantee an FCA share.

If your goal is to preserve options on both fronts, you should coordinate internal reporting, external complaints, and a potential qui tam case with counsel who understands relator status requirements and healthcare regulatory exposure. The Health Law Offices of Anthony C. Vitale, P.A. routinely walks healthcare professionals through this sequencing to avoid forfeiting FCA rights or escalating unnecessary risk.

For more detail on retaliation, confidentiality, and employment issues, see protecting your rights as a healthcare whistleblower.

Practical compliance tips for healthcare executives and professionals

From a healthcare compliance perspective, relator status requirements matter for two distinct groups: potential relators and organizations that may be defendants.

If you are considering stepping forward as a relator, you should:

Document facts, not speculation
Preserve relevant emails, billing reports, and meeting notes
Avoid self‑help data mining that violates HIPAA or internal access controls
Speak with experienced FCA counsel before you resign, confront leadership, or contact regulators

If you are on the organizational side, you should assume that informed insiders understand their relator options. That means:

Treat internal reports seriously and investigate promptly
Avoid retaliation that could increase your FCA exposure and strengthen a relator’s position
Align your compliance program with FCA enforcement trends so that systemic issues are detected internally before an employee files under seal

When you understand who can become a relator and what they must show, you are better positioned to manage risk on both sides of the equation.

Key takeaways

Relator status requirements focus on both who you are and what you know about fraud involving federal healthcare funds.
You must voluntarily provide specific, non‑frivolous insider information about false claims in order to qualify and remain eligible for a recovery share.
Certain categories such as active duty military in matters tied to their service, some government employees, and attorneys reporting on clients face added restrictions or outright bars.
You must follow strict filing and seal procedures and cooperate with DOJ during its investigation to protect your relator rights and credibility.
Not every whistleblower is a relator. FCA relator status is a narrow, legally defined role with unique rights, risks, and compliance implications.

FAQs about relator status requirements

1. Do you have to be an employee of the healthcare provider to qualify as a relator?
No. You do not have to be a current employee. Former employees, independent contractors, vendors, or other insiders with reliable non‑public information can qualify as relators. Trade associations and labor unions can also serve as relators if they possess qualifying information about fraud against the government (Wikipedia). What matters most is the quality and source of your information, not your title.

2. Can you still be a relator if the DOJ declines to intervene in your case?
Yes. If DOJ declines intervention after the seal period, you may proceed with the FCA case on behalf of the government as a private relator. Your potential percentage recovery is higher in that scenario, but the litigation burden and risk for you and your counsel increase significantly (USA Whistleblowers). You should evaluate the strength of your evidence and the financial viability of the case with experienced FCA counsel before moving forward.

3. What happens if your information about fraud is already public?
If the core allegations or transactions are already publicly disclosed, you may be barred from proceeding unless you qualify as an “original source” with independent knowledge that materially adds to the public information. Courts scrutinize this issue closely. Even if you can file, prior public disclosure can affect your credibility and your potential share of any recovery. You should have counsel assess public disclosure risk before filing.

4. Are you protected from retaliation if you pursue relator status?
Under the False Claims Act and other federal and state laws, you may be protected from retaliation for lawful efforts to stop FCA violations, even if you ultimately do not file or prevail in a qui tam case. Protection can extend to termination, demotion, harassment, and other adverse employment actions. However, you must still comply with confidentiality, HIPAA, and internal access rules. The safest approach is to coordinate your evidence gathering and reporting strategy with counsel who understands employment, regulatory, and FCA dynamics.

5. When should you involve The Health Law Offices of Anthony C. Vitale, P.A. if you suspect fraud?
You should speak with counsel as soon as you suspect systemic fraud involving federal healthcare funds and before you confront leadership, resign, or respond to government inquiries. Early advice allows you to preserve evidence lawfully, structure disclosures to maintain eligibility as a relator, and minimize your own civil, regulatory, or professional risk. The Health Law Offices of Anthony C. Vitale, P.A. can evaluate your potential case, walk you through the process of a qui tam or whistleblower lawsuit, and help you focus on protecting your rights as a healthcare whistleblower while the government investigates.

This article is for informational purposes only and does not constitute legal advice. Accreditation requirements vary by state and payor contract. Consult with a qualified attorney regarding your specific compliance obligations.